Salem Radio Network News Sunday, August 1, 2021

Health

Israel says signed MOU with NRX Pharmaceuticals for COVID vaccine trials

JERUSALEM (Reuters) – Israel has signed a memorandum of understanding with NRX Pharmeceuticals to complete trials and commercialize the Israeli-developed COVID-19 vaccine BriLife, Israel’s Defense Ministry said on Monday.

The vaccine was developed by the Israel Institute for Biological Research, which is overseen by the Defense Ministry.

(Reporting by Ari Rabinovitch; Editing by Steven Scheer)

Previous
Next

Editorial Cartoons

View More »

Michael Ramirez
Fri, Jul 23, 2021

X CLOSE